Basal Cell Carcinoma is a type of skin cancer. It usually appears as a slow-growing bump on the skin, often on sun-exposed areas like the face. It rarely spreads to other parts of the body.
Every report comes from a Lived member, sent anonymously.
Have you had Mohs Surgery for Basal Cell Carcinoma?
Basal cell carcinoma (BCC) is the most common type of skin cancer. It begins in basal cells, which sit in the deepest part of the skin's outer layer. It usually grows slowly and very rarely spreads to other parts of the body, which makes it far less dangerous than melanoma. Left untreated, though, it keeps growing into the surrounding tissue and can eventually damage cartilage, muscle or bone, which matters most on the face. Most BCCs appear on skin that has had years of sun, such as the face, ears, scalp, neck, shoulders and back. The most typical sign is a firm, raised bump that looks shiny or pearly. On lighter skin it is often pink or red; on darker skin it is often brown or black. Other BCCs look like a sore that bleeds, crusts and doesn't heal (or heals and then comes back), a scaly patch, a round area with a dip in the center, or a flat, waxy mark that resembles a scar. Many cause no pain at all, so a spot that simply won't go away is often the only clue.
Most BCCs are caused by ultraviolet (UV) light from the sun or from tanning beds and sunlamps. UV damages the DNA in skin cells, and that damage builds up over decades. This is why BCC is most common after age 50 and on the most sun-exposed skin. Sunburns, especially blistering ones in youth, add to the risk, and indoor tanning is one reason BCC now appears in younger adults too. People with very light skin, red or blonde hair, light eyes, or skin that freckles or burns easily have the highest risk, but people of every skin color develop BCC, sometimes on skin that gets little sun. Other risk factors include a previous skin cancer, a family history of skin cancer, a weakened immune system (for example, from medicines taken after an organ transplant), past radiation treatment, heavy exposure to arsenic, and a few rare inherited conditions, such as basal cell nevus syndrome (also called Gorlin syndrome), that cause many BCCs starting in childhood or the teen years. Having a risk factor does not mean someone will get BCC, and some people with no obvious risk factor still do.
Diagnosis starts with a close look at the spot, usually by a dermatologist, along with questions about your health, medicines and any past skin cancer. Several non-cancerous conditions, including psoriasis and some rashes, can look similar, so the only way to confirm BCC is a skin biopsy. After numbing the area, the clinician shaves off or punches out a small sample, and a doctor who specializes in reading tissue examines it under a microscope. Results usually come back within a few days. The biopsy shows more than whether cancer is present. Its findings, together with the tumor's size, location and whether it is new or has returned, help the team judge how likely the cancer is to grow deep or come back after treatment, and that judgment guides which treatment makes sense. Because people with one skin cancer often have others, a full-body skin exam usually follows. A CT or MRI scan is needed only when the cancer may have grown deep into muscle or bone or around a nerve.
The goal is to remove or destroy all of the cancer, and an early BCC is usually treated successfully with a single procedure. Surgery is the most common approach. In a standard excision, the tumor is cut out under local anesthetic along with a margin of normal-looking skin, and a lab checks the edges for any remaining cancer cells. For small, low-risk tumors on the trunk, arms or legs, curettage and electrodesiccation is a quick office alternative: the tumor is scraped away and the base is heated to destroy what is left. Mohs surgery is used for BCCs on the nose, eyelids, ears, forehead, scalp, hands, feet or genitals, for large tumors or ones with unclear edges, and for cancers that have come back. The surgeon removes a thin layer, examines its edges under the microscope while you wait, and removes more only where cancer remains. This spares as much healthy skin as possible and gives the highest cure rate, with the cancer returning in fewer than 5 in 100 cases. It takes longer and is more complex than a standard excision, so it is not usually needed for low-risk tumors. For low-risk tumors, or for people who cannot have surgery, non-surgical options include prescription creams such as imiquimod or fluorouracil applied at home for several weeks (approved only for superficial BCC, which is confined to the top layer of skin), photodynamic therapy (a light-sensitizing medicine activated by a special light), freezing with liquid nitrogen, and radiation. These avoid a cut but cure fewer cancers; after some of them the cancer returns in 15 in 100 cases or more. The creams cause expected redness, crusting and soreness while they work and make the skin burn more easily in the sun. For the uncommon BCC that has grown deeply or spread, treatment may combine larger surgery and radiation with medicine. Vismodegib (Erivedge) and sonidegib (Odomzo) are capsules that block hedgehog signaling, a growth pathway that is overactive in most BCCs. They can shrink tumors in some people, but muscle spasms, hair loss and taste changes are common. Both can cause pregnancy loss or severe birth defects, so pregnancy is ruled out before starting, effective contraception is needed during treatment and for up to about two years afterward (the exact time depends on the medicine), and men taking them should use condoms with a partner who could become pregnant during treatment and for several months afterward. Cemiplimab (Libtayo), an immunotherapy given by infusion every three weeks, is an option when these pills have stopped working or are not suitable.
Most people with BCC are cured, often with one office procedure done while they are awake. A scar is the usual lasting result, and it keeps changing for a year or more before it flattens and becomes less noticeable. When more skin has to be removed, for example on the nose or eyelid, the wound may be closed with a skin flap or graft. Delaying treatment usually means a larger operation and a bigger scar later, because the tumor keeps spreading through the skin. The longer-term issue is that BCC tends to come back or appear elsewhere. A treated tumor can recur in the same spot, and people who have had one BCC are at high risk of new skin cancers in other places. Follow-up skin exams are often scheduled every 6 to 12 months, and dermatologists generally recommend checking your own skin about once a month, with a partner or a mirror for hard-to-see areas. Protecting your skin from the sun with shade, clothing and sunscreen, and avoiding tanning beds, lowers the chance of new cancers. A small number of people with advanced BCC need ongoing treatment to keep the cancer in check for as long as possible.
Make an appointment with a dermatologist or your primary care clinician for any spot that is growing, bleeding, crusting, not healing or changing in any way, especially on sun-exposed skin. If you have already had BCC, contact your care team when you notice a change in or around a treated scar or a new suspicious spot, rather than waiting for the next scheduled check. If you are taking vismodegib or sonidegib and you or your partner may be pregnant, contact your prescriber right away. If a treatment cream causes a reaction you cannot tolerate, call your dermatologist, who may advise a short break.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Basal Cell Carcinoma is like, what's helped you, or ask the community a question.